Industry News's blog

DMCA.com Protection Status
Industry News's picture
Keywords: 

By Industry News

SALT LAKE CITY, Jan. 18, 2022 -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, announced today that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IND) application for the evaluation of SkinTE for the treatment of chronic cutaneous ulcers.

Blog Category: 
Industry News's picture
Keywords: 

By Industry News

TORONTO, ONTARIO – January 18, 2022 MolecuLight Inc., a provider in point-of-care, fluorescence imaging for the detection of elevated bacterial loads within wounds, announced the publication of “Uncovering the High Prevalence of Bacterial Burden in Surgical Site Wounds with Point-of-Care Fluorescence Imaging”1 in the International Wound Journal.

Blog Category: 
Industry News's picture
Keywords: 

By Industry News

DALLAS, TEXAS and TORONTO, ONTARIO, January 4, 2022 – MolecuLight Inc., a provider in point-of-care, fluorescence imaging for the detection of elevated bacterial loads within wounds announces that SWK Holdings Corporation has provided $10M USD structured debt to support MolecuLight’s global commercial expansion. SWK Holdings Corporation (Nasdaq: SWKH) is a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies through the creation of unique financing structures. These deals include structured debt, traditional royalty monetization, synthetic royalty transactions and asset purchases, and typically range in size from $5 million to $20 million, a market segment often ignored by other structured finance companies.

Blog Category: 
Industry News's picture
Keywords: 

By Industry News

ATLANTA, December 22, 2021 - SoftWave Tissue Regeneration Technologies (SoftWave TRT) announced an agreement to supply Cynosure LLC, a provider in medical aesthetics, with its patented extracorporeal shock wave devices for distribution in the United States and Canada primarily to medical doctors and their practices.

Blog Category: 
Industry News's picture
Keywords: 

By Industry News

Malvern, PA—Dec 09, 2021 - New from WoundCon—the first and largest global virtual wound care conference—comes a fully interactive and uniquely immersive virtual event. With free attendance for licensed health care professionals, Wound Management in Post-Acute Care: The Patient Journey provides an exploration of case-based scenarios complemented by real-time engagement with course faculty, instant polling, and interactive exercises—all focused on providing the knowledge and tools today that can be put into action tomorrow.

Blog Category: 
Industry News's picture
Keywords: 

By Industry News

Miami, FL – December 2, 2021 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company, announced today that it has gifted the American Diabetes Association (ADA) with a $10,000 donation to support scientific research and prediabetes education.

Blog Category: 
Industry News's picture
Keywords: 

By Industry News

Sarasota, FL, September 2, 2021—Omeza, a skin science company, announced that the U.S. Food and Drug Administration (FDA) cleared Omeza® Collagen Matrix through the FDA 510(k) premarket notification process. Omeza® Collagen Matrix is Omeza’s first Rx product, and the first drug/device combination matrix of its kind for chronic wound care.

Blog Category: 
Industry News's picture
Keywords: 

Wound Care News

Toronto, ONTARIO and Las Vegas, NEVADA– (October 28, 2021 -MolecuLight Inc., a provider of in point-of-care fluorescence imaging for the detection of wounds that contain elevated bacterial loads, announces the presentation of 7 clinical posters and presentations at the Symposium of Wound Care (SAWC) Fall 2021, held from October 29 – 31, 2021 in Las Vegas, Nevada.

Blog Category: 
Industry News's picture
Keywords: 

By Industry News

Jacksonville, FL – Oct. 27, 2021 – Next Science Limited, a medical technology company, announced that it will exhibit at the Symposium on Advanced Wound Care Fall meeting (SAWC Fall) from Oct. 29-31. Next Science, whose mission is to heal patients and save lives by addressing the impact of biofilms on human health, will exhibit at Booth No. 718.

Blog Category: 
Industry News's picture
Keywords: 

By Industry News

Toronto, Canada– September 23, 2021 – MolecuLight Inc., the creator of a point-of-care fluorescence imaging device for real-time detection of wounds containing elevated bacterial loads, announces that it has received FDA 510(k) clearance for the detection of wounds containing clinically significant levels (>104 CFU/g) of Pseudomonas aeruginosa (PA) for the previously cleared MolecuLight i:X imaging device. The i:X device visualizes fluorescence, enabling the point-of-care detection of wounds containing elevated levels of bacteria. This new FDA clearance supports the ability of the i:X device to increase the clinician’s ability to detect the presence of Pseudomonas aeruginosa in wounds using the cyan fluorescence signal. This augmented labeling is based on a detailed retrospective statistical analysis of over 350 patients.

Blog Category: 

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.